SCHEMBL14224804

SCHEMBL14224804

CCOOC(=O)c1cc(NC(=O)c2sccc2Cl)cn1CCCN(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.37
SENP8 Q96LD8 3/20 0.37
SENP7 Q9BQF6 3/20 0.37
SENP6 Q9GZR1 3/20 0.37
F10 P00742 3/20 0.36
TLR8 Q9NR97 1/20 0.36
PRSS12 P56730 2/20 0.35
ALDH1A1 P00352 5/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 5/20 0.34
KDM4E B2RXH2 4/20 0.34
MEN1 O00255 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
CYP2D6 P10635 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13919671 0.75 HDAC1 (0.48) F10MAPTKDM4EHPGDPOLB
SCHEMBL14224752 0.74 PRSS12 (0.42) CASP3SENP8SENP7SENP6F10
SCHEMBL14224803 0.72 FPR1 (0.42) CASP3SENP8SENP7SENP6ALDH1A1
SCHEMBL14427753 0.71 SMN1; SMN2 (0.41) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL14224805 0.70 HDAC1 (0.33) CASP3SENP8SENP7SENP6PRSS12
SCHEMBL13919908 0.70 F10 (0.43) F10TLR8PRSS12ALDH1A1KMT2A
SCHEMBL14427754 0.69 L3MBTL1 (0.42) ALDH1A1MAPTKDM4EL3MBTL1TSHR
SCHEMBL13919912 0.67 F10 (0.45) CASP3SENP8SENP7SENP6F10
SCHEMBL13919939 0.67 HRAS (0.42) ALDH1A1KMT2AMAPTKDM4ECYP3A4
SCHEMBL14224538 0.65 AVPR2 (0.45) ALDH1A1KMT2AMAPTMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 CASP3 22/4885SENP8 3347/4885SENP7 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.